Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119475) titled 'Clinical study evaluating the impact of XY03-EA tablets on the human pharmacokinetics of the transporter OAT1 substrate adefovir dipivoxil in participants of a health research study' on Feb. 27.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shulan (Hangzhou) Hospital
Condition:
Acute ischemic stroke
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-04
Target Sample Size: Experimental group:14;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=311748
Published by HT Digital Content Services wi...